Chasing the wind to catch the moon do not stay, the barren is spring mountain
Focus on precision medicine to solve the mystery of bacterial flora
-
Fojann News
On the journey of exploring the clinical aspects of LBP | Lishan Biology, hand in hand with Duxact Biology, continues to create new history.
On June 19, 2025, at the headquarters building of Duxact Biology in Changsha, Lishan Biology and Duxact Biology, a leading domestic CRO enterprise, officially reached a strategic cooperation to jointly promote the clinical trial of the live biotherap
Shanghai2025-06-19 -
Fojann News
Lishan Bio | Digital Management Platform for Innovative Drugs Passes Expert Review with Targeted Improvements
On the morning of May 15, 2025, the Zhangjiang China Pharma Valley Conference Room hosted a review panel led by the Pudong New Area Science and Technology Commission to evaluate the digital transformation achievements of Shanghai Lishan Bio.
Shanghai2025-05-15 -
Fojann News
Lishan Bio's Chairman Chen Weijie Awarded the Annual Innovative Entrepreneur Prize among the Top 100 of Future Medical (VBEF)
As time passes, magnificent chapters are born, and in the pleasant spring scenery, good news spreads. On May 9, 2025, Dr. Chen Weijie, Chairman of Lishan Bio, was awarded the VBEF Annual Innovative Entrepreneur Award.
Shanghai2025-05-09 -
Fojann News
Lishan Bio and Renji Hospital Punan Branch Discussed the "Five-in-One" Solution of Industry, Academic, Research, Supply and Marketing
On the afternoon of March 21, 2025, Dr. Chen Weijie, Chairman of Shanghai Lishan Biomedical Co., Ltd. and Dr. Zhu Chaoyu, General Manager of Fojann Intelligence (Shanghai) Pharmaceutical Co., Ltd. were invited to the Punan Branch of Renji Hospital af
Shanghai2025-03-21 -
Fojann News
Lishan Biological IBD pipeline is commercialized as scheduled
The inflammatory bowel disease (IBD) pipeline of Shanghai Lishan Biomedicine Co., Ltd. has completed all the preparatory work for the previous FDA application, and will carry out the IND application of FDA in November this year, fully opening a new c
Shanghai2024-09-25 -
Fojann News
Lishan Biology will soon contribute AI drug discovery and validation platform to the industry
On August 27, 2024, on the occasion of the first anniversary of the Joint Laboratory of Intelligent Microbiome jointly established by Lishan Biomedicine Co., Ltd. and Fudan University, Zhuang Kesing, director of Lishan Biological Advisory Committee,
Shanghai2024-08-29
Shanghai Public Network Anbei 31011502402974